Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The clinical interview for depression. Development, reliability and validity.

E S Paykel

    Journal of Affective Disorders
    |July 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Which depressions are related to life stress?

    Acta neuropsychiatrica·2016
    Same author

    Treatment of unipolar major depression: Algorithms for pharmacotherapy.

    International journal of psychiatry in clinical practice·2014
    Same author

    Antidepressants: Their efficacy and place in therapy.

    Journal of psychopharmacology (Oxford, England)·2011
    Same author

    Melancholia.

    Journal of psychopharmacology (Oxford, England)·2011
    Same author

    Partial remission, residual symptoms, and relapse in depression.

    Dialogues in clinical neuroscience·2009
    Same author

    Do treated psychiatric patients become later community cases? A prospective cohort study.

    European psychiatry : the journal of the Association of European Psychiatrists·2006
    Same journal

    Corrigendum to "Effects of neuronavigation-guided rTMS on serum BDNF, TrkB and VGF levels in depressive patients with suicidal ideation" [J. Affect. Disord. 323 (2023) 617-623].

    Journal of affective disorders·2026
    Same journal

    Transcutaneous vagus nerve stimulation enhances reward-effort efficiency in severe major depressive disorder.

    Journal of affective disorders·2026
    Same journal

    Age-varying associations between attitudes toward suicide and suicidal ideation in Chinese psychiatric outpatients.

    Journal of affective disorders·2026
    Same journal

    Aripiprazole once-monthly for patients diagnosed with bipolar I disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed.

    Journal of affective disorders·2026
    Same journal

    The perils of perfection: A prospective population-based cohort study of perfectionism and depression in young adults.

    Journal of affective disorders·2026
    Same journal

    Dissociable patterns of alpha-band connectivity and structural-functional coupling in major depressive disorder with mixed features.

    Journal of affective disorders·2026
    See all related articles

    This study presents a reliable and valid symptom rating scale for assessing depression and neurotic disorders. The scale effectively measures patient symptoms during interviews and is suitable for various clinical research applications.

    Area of Science:

    • Psychiatry and Clinical Psychology
    • Mental Health Assessment

    Background:

    • Depression and mixed neurotic disorders require accurate assessment tools.
    • Existing rating scales may have limitations in reliability or validity.

    Purpose of the Study:

    • To describe and summarize data on a novel symptom rating scale.
    • To evaluate the scale's reliability and validity for assessing depression and neurotic disorders.

    Main Methods:

    • Development of a symptom rating scale with seven-point anchor-defined items.
    • Assessment of scale reliability with psychiatrists and non-medical raters.
    • Evaluation of validity through correlations with other scales, sensitivity to change, and treatment discrimination.

    Main Results:

    Related Experiment Videos

    • The scale demonstrated reliability across different rater types.
    • Evidence of validity was established through multiple metrics including internal consistency and factorial structure.
    • The scale proved sensitive to change and effective in discriminating treatment effects.

    Conclusions:

    • The developed symptom rating scale is a reliable and valid instrument.
    • The scale is suitable for descriptive, classification, outcome studies, and treatment trials in depression and neurotic disorders.